Utilization of Schizochytrium mangrovei PQ6 as feed for rotifer Brachionus plicatilis in rearing black sleeper’s larvae (Bostrichthys sinensis, Lacepede, 1881)

 Schizochytrium mangrovei PQ6 contains many important polyunsaturated fatty acids, such as docosahexaenoic acid (DHA, C22: 6w-3), eicosahexaenoic acid (EPA, C20: 5w-3) and docosapentaenoic acid (DPA, C22: 5w-6). These fatty acids are essential for survival and growth of many marine fish larvae. In this paper, fresh biomass of S. mangrovei PQ6 was used for culturing rotifer Brachionus plicatilis. In the first formula (L1), rotifers were fed on baker’s yeast; in second formula (L2), rotifers were fed on mixed two microalgae, Nannochloropsis oculata and Chaetoceros gracilis; in the third formula (L3), rotifers were fed on S. mangrovei PQ6 biomass. The results indicated that S. mangrovei PQ6 biomass can replace baker’s yeast and autotrophic microalgae in feeding rotifers. Total lipid, total fatty acid and polyunsaturated fatty acid contents of rotifers fed on formula 3 (S. mangrovei PQ6) were higher than those within others. High polyunsaturated fatty acid (C ≥ 20) in omega-3 and 6 groups; DHA and DPA contents of rotifers fed on S. mangrovei PQ6 were the highest, accounting for 39.81% of total fatty acid; 41.95% and 8.24% polyunsaturated fatty acids, corresponding to 20.52; 12.15 and 2.4 mg/g of dried weight, respectively.The survival rate of black sleeper’s larvae was highest when they were fed on rotifers grown on L3 formula (51.20 ± 0.89%), followed by L2 formula (48.70 ± 2.67%) and the lowest with L1 formula (43.44 ± 1.54%) (P 0.05). However, among three formulas, no significant difference was found in the growth of black sleeper’s larvae (P 0.05). These results suggest that biomass of S. mangrovei PQ6 can replace traditional feed like autotrophic microalgae or baker’s yeast for biomass culture of the Brachionus plicatilis rotifer for rearing black sleeper’s larvae to enhance seed quality to meet demands of market.

Safety assessment and the effect of squalene isolated from schizochytrium mangrovei pq6 on serum hdl - cholesterol levels in animal models

In this paper, the acute and subchronic toxicity and the effect of squalene isolated from heterotrophic marine microalga Schizochytrium mangrovei PQ6 on the serum levels of HDL-C were investigated using animal models. The results of acute toxicity study showed that by oral administration of the squalene on albino mice at the highest dose of 58.25 g/kg of whole body of mice/day, the LD50 was not determined. Squalene at doses of 400 mg and 1,200 mg/kg/day for 60 consecutive days have allowed the normal behavior, body weight, hematological and biochemical parameters, liver and kidney functions, morphology of liver, kidney and spleen, total plasma cholesterol content, however, HDL-C level was higher in squalene treated mices compared to control group (p 0.05). In addition, at doses of 600 and 1,200 mg/kg/day for 60 continuous days, squalene treated mice showed the increase in HDL-C level and HDL-C/total cholesterol ratio and the decrease in the contents of LDL-C and VLDL-C without affecting the body and liver weights and levels of total cholesterol and triglyceride.  

The impact of zerovalent cobalt nanoparticle on photosynthesis - related genes expression in soybean leaves Glycine max (L.) Merr. (Dt26)

Photosynthesis is an important physiological process in plants. It plays a crucial role in plant growth and development. In this study, we investigated the impact of zerovalent cobalt nanoparticles on the photosynthesis and expressing of gene involving in this process in leave of soybean Glycine max (L) Merr “DT26” at different growth stages. The results showed that treatment of zerovalent cobalt nanoparticles made in Vietnam and USA (with two doses of 0.17 and 16.67 mg/kg of soybean seed) enhanced the photosynthesis of soybean by increasing the content of chlorophyll a and the ratio of Fv/Fm compared with the control (without treatment of zerovalent cobalt nanoparticles). These values tended to increase and reached the maximum value at 40 days and then decreased in at 70 days. The expression level of photosynthesis-related genes of soybean leaves also changed depending on the soybean’s growth stage and concentration of zerovalent cobalt nanoparticles being treated. The genes psaA, Lhca, psaB, Cytb6f (belonging to photosystem I) and psbA, psbB, psbC, psbD, psbE (belonging to photosystem II) in the experimental fomulas were higher expressed than that in control group at 20 and 70 days. However, at 40 days, the expression levels of these genes were significantly different. Obtained results supplied the basis for understanding the active mechanism of the above genes to control/regulates photosynthetic activity of plants with and without the presence of zerovalent cobalt nanoparticles as well as under stress conditions. 

Nucling Regulates Mammary Gland Involution

Postpartum mammary gland involution is the physiological process by which the lactating gland returns to its pre-pregnant state. In rodent models, the microenvironment of mammary gland involution is sufficient to induce enhanced tumor cell growth, local invasion, and metastasis. Therefore, a deeper understanding of the physiological regulation of involution may provide in-depth information on breast cancer therapy. We herein identified Nucling as an important regulator of involution of the mammary gland. A knock-out mouse model was generated and revealed that postpartum involution were impaired in mice lacking Nucling. Involution is normally associated with an increase in the activation of NF-κB and STAT3, which is required for the organized regulation of involution, and was observed in WT glands, but not in the absence of Nucling. Furthermore, the loss of Nucling led to the suppression of Calpain- 1, IL-6, and C/EBPδ factors, which are known to be essential for normal involution. The number of M2 macrophages, which are crucial for epithelial cell death and adipocyte repopulation after weaning, was also reduced in Nucling-KO glands. Taken together, the results of the present study demonstrated that Nucling played an important role in mammary gland involution by regulating NF-κB and STAT3 signaling pathways

Лексические средства связности в речи телеведущего в жанре интерактивной белорусскоязычной телебеседы

Материалы XII Междунар. науч. конф. студентов, магистрантов, аспирантов и молодых ученых, Гомель, 16–17 мая 2019 г

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Background Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethnically diverse population. Methods AFFINITY was a randomised, parallel-group, double-blind, placebo-controlled trial done in 43 hospital stroke units in Australia (n=29), New Zealand (four), and Vietnam (ten). Eligible patients were adults (aged ≥18 years) with a clinical diagnosis of acute stroke in the previous 2–15 days, brain imaging consistent with ischaemic or haemorrhagic stroke, and a persisting neurological deficit that produced a modified Rankin Scale (mRS) score of 1 or more. Patients were randomly assigned 1:1 via a web-based system using a minimisation algorithm to once daily, oral fluoxetine 20 mg capsules or matching placebo for 6 months. Patients, carers, investigators, and outcome assessors were masked to the treatment allocation. The primary outcome was functional status, measured by the mRS, at 6 months. The primary analysis was an ordinal logistic regression of the mRS at 6 months, adjusted for minimisation variables. Primary and safety analyses were done according to the patient's treatment allocation. The trial is registered with the Australian New Zealand Clinical Trials Registry, ACTRN12611000774921. Findings Between Jan 11, 2013, and June 30, 2019, 1280 patients were recruited in Australia (n=532), New Zealand (n=42), and Vietnam (n=706), of whom 642 were randomly assigned to fluoxetine and 638 were randomly assigned to placebo. Mean duration of trial treatment was 167 days (SD 48·1). At 6 months, mRS data were available in 624 (97%) patients in the fluoxetine group and 632 (99%) in the placebo group. The distribution of mRS categories was similar in the fluoxetine and placebo groups (adjusted common odds ratio 0·94, 95% CI 0·76–1·15; p=0·53). Compared with patients in the placebo group, patients in the fluoxetine group had more falls (20 [3%] vs seven [1%]; p=0·018), bone fractures (19 [3%] vs six [1%]; p=0·014), and epileptic seizures (ten [2%] vs two [<1%]; p=0·038) at 6 months. Interpretation Oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and epileptic seizures. These results do not support the use of fluoxetine to improve functional outcome after stroke

Phytic Acid Extracted from Rice Bran as a Growth Promoter for Euglena gracilis

A significant promotion of growth and accumulation of metabolites of freshwater microalga Euglena gracilis was obtained by adding phytic acid to the culture. Phytic acid concentration of 0.05% (v/v) showed a maximum biomass increase of 1.6-fold compared to the control group. Synchronous variation in the content and proportion of photosynthetic pigments was also observed. The total chlorophyll content increased with phytic acid concentration, suggesting the enhanced capacity of absorbing light. Cell length, an important biomarker for E. gracilis, was prolonged to a certain extent under light condition, indicating the state of the cells was more active. Since phytic acid is derived from agro waste of rice bran, it is promising as a low-cost but high-efficient growth promoter of E. gracilis